DOSAGE REGIMEN FOR HIV VACCINE
The present invention relates to a novel dosage regimen in the treatment of HIV infections and AIDS. In particular, the present invention relates to a specific novel use of formulations of HIV-specific protein therapeutics, such as anti-HIV-1 specific antibodies and/or HIV-specific vaccine peptides,...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a novel dosage regimen in the treatment of HIV infections and AIDS. In particular, the present invention relates to a specific novel use of formulations of HIV-specific protein therapeutics, such as anti-HIV-1 specific antibodies and/or HIV-specific vaccine peptides, administered in a dosing regimen together with a latent viral reservoir purging agent. The formulations may further be administered with one or more other therapeutic agents, such as in combination with at least one immunomodulatory compound and/or other reservoir purging agents, such as histone deacetylase (HDAC) inhibitors. |
---|